by Laura Smith | Dec 12, 2023 | Weekly Cannabis News, Weekly News
States grapple with judicial, regulatory and legislative uncertainty. Advice on healthy consumption, increased use among seniors, and it turns out marijuana consumers are nicer people. DEA warns a Georgia pharmacy the marijuana is still illegal...
by Laura Smith | Sep 28, 2023 | Uncategorized
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant...
by Laura Smith | Sep 26, 2023 | Blog, Communications, Science
There are formidable challenges in conducting studies involving cannabis. Understanding Clinical Trials Before we delve into the complexities of cannabis clinical trials, let’s establish what clinical trials are. These rigorous scientific experiments play a...
by Laura Smith | Sep 12, 2023 | Weekly Cannabis News, Weekly News
In response to last week’s Health and Human Services (HHS) announcement 14 Senators authored a letter to the Drug Enforcement Agency (DEA)asking them to reject the recommendation to reschedule cannabis. A brief look at what rescheduling might mean. In the wake...
by Laura Smith | Aug 30, 2023 | Weekly Cannabis News, Weekly News
The most significant development this week revolves around the recommendation by the Department of Health and Human Services (HHS) to reclassify marijuana as a Schedule III drug. In addition to this noteworthy announcement, there are a couple of other intriguing...
